Category: Imaging & mpMRI
A prominent urologist wrote an articulate article on how the U.S. Preventive Services Task Force made a recommendation against broad PSA screening based on an oversimplification of a complex issue. He made an eloquent declaration on several ways in which urologists are “embracing strategies to preserve, or even further decrease, prostate cancer mortality while minimizing keep reading
It’s always reassuring to receive affirmation, especially when offering a leading edge medical program to prostate cancer patients. Such was the case for us at the Sperling Prostate Center with the December, 2015 publication of a UCLA Medical Center study on the value-added of multiparametric MRI during Active Surveillance (AS). The authoritative Journal of Urology keep reading
Nanoparticles are very, very small objects that have the properties of the larger unit from which they are derived. Nanoparticles sound like something discovered by physicists, but in fact they have been used by artisans for over 1,000 years to add metallic luster to the surface of pottery and other artistic creations. Today, medical science keep reading
“Everyone is keeping up with the Joneses, and there are more Joneses than ever.” This statement from art critic Jerry Saltz refers to the buying habits of a public hungry for trendy art. However, it could as easily apply to MRI technology, where the strength of the magnet—measured in units called Tesla, or T—makes all keep reading
Back in May, I posted an article on our website about Haralick texture analysis as an amplification of prostate cancer features on multiparametric MRI. On July 28, a journal article on which I based the piece I posted was picked up by a medical news service, so I thought it was worth bringing attention to keep reading
By: Dan Sperling, MD Many focal laser ablation patients, and those considering this targeted prostate cancer treatment, are eagerly anticipating the May 15-19 American Urological Association meeting in New Orleans. Given that the majority of urologists are not exactly FLA-friendly, why would fans of our pioneering and elegant therapy set their sights on this meeting? keep reading
One of the most respected U.S. urologists is Dr. E. David Crawford, Professor of Surgery, Urology, and Radiation Oncology, and head of the Section of Urologic Oncology at the University of Colorado Anschutz Medical Campus. He gave a presentation to the plenary session of the recent European Association of Urology meeting in Madrid, on the keep reading
The annual Genitourinary Cancers Symposium is a three day professional meeting on cancers related to the prostate, bladder, kidneys, and other organ systems related to urinary and sexual function. Prostate cancer has an entire poster section devoted just to this disease. At the Feb. 26-28, 2015 symposium on Orlando, one of the general presentation sessions keep reading
An international team of experts on imaging prostate cancer participated in a review of the literature on prostate MRI and active surveillance.[i] To give you an idea of how impressive the team was, here is a list of the institutions they represent: Erasmus University Medical Center (Depts. of Urology and Radiology), Rotterday, the Netherlands University keep reading
A man who is suspected of having prostate cancer, or whose cancer has been biopsy confirmed, can develop the best right treatment plan if he also has a multiparametric MRI (mpMRI) of the prostate. When his own doctor sends him to an imaging center, his scan is “read” by the center’s radiologist who writes a keep reading
